Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race
Bristol Myers provides Bridge over troubled water with $905M deal [...]
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom
After 20 years, Boehringer vet hits the exit to become [...]
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data
Bristol Myers on track for 3rd new drug launch of [...]
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T [...]
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute ‘false and speculative narrative’ at trial
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging [...]
Welcome to new (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal
Welcome to new (Bio) Haven: CEO hopes to strike gold [...]
Novo Nordisk, Flagship’s forward-thinking partnership aims to treat cardiometabolic, rare diseases
Novo Nordisk, Flagship’s forward-thinking partnership aims to treat cardiometabolic, rare [...]
Rallybio wades into Sanofi storeroom for $3M rare disease deal
Rallybio wades into Sanofi storeroom for $3M rare disease deal [...]
Cortexyme shakes things up with Novosteo acquisition, leadership change and a new name
Cortexyme shakes things up with Novosteo acquisition, leadership change and [...]
Starting gun? $11.6B M&A domino falls as Pfizer scoops up Biohaven for phase 3 migraine nasal spray
Starting gun? $11.6B M&A domino falls as Pfizer scoops up [...]